Literature DB >> 8005878

Effects of inhaled NO and inhibition of endogenous NO synthesis in oxidant-induced acute lung injury.

B P Kavanagh1, A Mouchawar, J Goldsmith, R G Pearl.   

Abstract

Inhaled nitric oxide (NO) decreases pulmonary arterial pressure (Ppa) and improves oxygenation in the adult respiratory distress syndrome. Endogenous NO can modulate the development of acute tissue injury. We investigated the effects of inhaled NO and of inhibition of endogenous NO synthase in oxidant-induced acute lung injury in the isolated buffer-perfused rabbit lung. A rapid (45 min) and a more gradual (3 h) model of oxidant-induced acute lung injury were developed using the production of superoxide free radicals from the reaction of purine with low and high doses of xanthine oxidase, respectively. The effects of rapid injury included increases in Ppa, precapillary pulmonary vascular resistance, capillary filtration coefficient (Kfc), and lung weight. In the gradual-injury model, only lung weight and Kfc increased. Pretreatment with inhaled NO (90-120 ppm) prevented the rise in Ppa and precapillary pulmonary vascular resistance in the rapid-injury model and prevented elevation of Kfc in the gradual-injury model. Pretreatment with an inhibitor of endogenous NO synthase (NG-nitro-L-arginine methyl ester) resulted in increased pulmonary capillary pressure and postcapillary pulmonary vascular resistance in the rapid-injury model and increased peak Ppa, pulmonary capillary pressure, and pulmonary vascular resistance in the gradual-injury model. These data suggest that in oxidant-induced acute lung injury 1) inhaled NO may attenuate increases in capillary permeability and 2) endogenous NO may function as a modulator of pulmonary vascular tone without affecting capillary permeability.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8005878     DOI: 10.1152/jappl.1994.76.3.1324

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  9 in total

1.  NO news is good news.

Authors:  M Sair; T W Evans
Journal:  Thorax       Date:  1995-04       Impact factor: 9.139

2.  Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants.

Authors:  N V Subhedar; S W Ryan; N J Shaw
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-11       Impact factor: 5.747

3.  Randomised trial of three doses of inhaled nitric oxide in acute respiratory distress syndrome.

Authors:  S F Tang; M C Sherwood; O I Miller
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

4.  Immunomodulation of pneumococcal pulmonary infection with N(G)-monomethyl-L-arginine.

Authors:  Y Bergeron; N Ouellet; M Simard; M Olivier; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

5.  Propofol attenuates oxidant-induced acute lung injury in an isolated perfused rabbit-lung model.

Authors:  Masato Yumoto; Osamu Nishida; Fujio Nakamura; Hirotada Katsuya
Journal:  J Anesth       Date:  2005       Impact factor: 2.078

6.  Stimulators of soluble guanylyl cyclase: future clinical indications.

Authors:  Bobby D Nossaman; Philip J Kadowitz
Journal:  Ochsner J       Date:  2013

7.  Ferritin and desferrioxamine attenuate xanthine oxidase-dependent leak in isolated perfused rat lungs.

Authors:  Brooks M Hybertson; Kevin G Connelly; Raquel T Buser; John E Repine
Journal:  Inflammation       Date:  2002-08       Impact factor: 4.092

Review 8.  Oxidative Stress and Microvessel Barrier Dysfunction.

Authors:  Pingnian He; M A Hassan Talukder; Feng Gao
Journal:  Front Physiol       Date:  2020-05-27       Impact factor: 4.566

Review 9.  Dynamics of pulmonary endothelial barrier function in acute inflammation: mechanisms and therapeutic perspectives.

Authors:  Holger C Müller-Redetzky; Norbert Suttorp; Martin Witzenrath
Journal:  Cell Tissue Res       Date:  2014-03-06       Impact factor: 5.249

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.